Ependymoma Active Not Recruiting Phase 2 Trials for Selumetinib (DB11689)

Also known as: Brain Ependymoma / Ependymoma of Brain / Ependymomas / Ependymoma (morphologic abnormality) / Ependymoma (disorder) / Ependymoma of brain (disorder)

IndicationStatusPhase
DBCOND0017183 (Ependymoma)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03095248Trial of Selumetinib in Patients With Neurofibromatosis Type II Related TumorsTreatment